CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy
Clinical trial NCT02537977 · UNKNOWN
Trial details
- NCT number
- NCT02537977
- Sponsor
- Shanghai Tongji Hospital, Tongji University School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2020-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.